We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Kirsten Crain Borden Ladner Gervais LLP

Results 1 to 5 of 5



Thannikkotu v. Board of Directors, Trillium Health Centre *

Canada - June 15 2012
Dr. Thannikkotu, a cardiac surgeon with 11 years experience in the United States, was appointed as a surgical assistant at the Trillium Health Centre.


Consultation on PMPRB guidelines *

Canada - May 9 2012
The Patented Medicine Prices Review Board is responsible for ensuring that patentees are not selling medicines at excessive prices in any market in Canada.

Co-authors: Barbara McIsaac, Q.C. .


Ratiopharm found to be patentee for purposes of PMPRB jurisdiction *

Canada - June 6 2011
ratio-Salbutamol HFA is an authorized generic version of VENTOLIN HFA, sold in Canada by GSK.


Other cases of Penlac® decision from PMPRB (Order) *

Canada - February 7 2011
The Patented Medicine Prices Review Board (the Board) has ordered sanofi-aventis Canada Inc. (sanofi) to pay $9.4 million for excessive revenues relating to the sale of Penlac®, a nail lacquer for treatment of a fungal infection of the nail.


Supreme Court of Canada confirms Patented Medicine Prices Review Board interpretation of the term “sold in any market in Canada” and underlines the consumer protection purposes of the board’s role *

Canada - January 21 2011
On January 20th the Supreme Court of Canada issued a decision which confirms the role of the Patented Medicine Prices Review Board (PMPRB) and the consumer protection purposes of ss.

Co-authors: Barbara McIsaac, Q.C. .